Hodgkin lymphoma may be treated with chemotherapy, radiation therapy, and stem-cell transplantation.[4] The choice of treatment often depends on how advanced the cancer has become and whether or not it has favorable features.[4] If the disease is detected early, a cure is often possible.[9] In the United States, 88% of people diagnosed with Hodgkin lymphoma survive for five years or longer.[5] For those under the age of 20, rates of survival are 97%.[13] Radiation and some chemotherapy drugs, however, increase the risk of other cancers, heart disease, or lung disease over the subsequent decades.[9]
In 2015, about 574,000 people globally had Hodgkin lymphoma, and 23,900 (4.2%) died.[6][7] In the United States, 0.2% of people are affected at some point in their life.[5] Most people are diagnosed with the disease between the ages of 20 and 40.[5]
^Cite error: The named reference Lozano_2012 was invoked but never defined (see the help page).
^ abcArmitage JO (August 2010). "Early-stage Hodgkin's lymphoma". The New England Journal of Medicine. 363 (7): 653–662. doi:10.1056/NEJMra1003733. PMID20818856.
^Hodgkin T (1832). "On some morbid experiences of the absorbent glands and spleen". Med Chir Trans. 17: 69–97.
^Grewal R, Irimie A, Naidoo N, Mohamed N, Petrushev B, Chetty M, Tomuleasa C, Abayomi EA (March 2018). "Hodgkin's lymphoma and its association with EBV and HIV infection". Critical Reviews in Clinical Laboratory Sciences. 55 (2): 102–114. doi:10.1080/10408363.2017.1422692. PMID29316828. S2CID46790198.